About
Kjell Mortier (Pharm., PhD) is a Fund Manager at Novalis. He has around 20 years of experience in the biotech industry across scientific roles in large pharma and CDMO companies, including work on bioanalytical and immunogenicity aspects of (pre-)clinical programs at Ablynx (now part of Sanofi) and CMC-analytical support and technology evaluation at the CRO Eurofins. He also holds a certification in financial analysis from EHSAL Management School.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- Mobio ConsultOwner and managing directorcurrent2019 — present
- CLOUDS OF CAREBoard Observer2025 — 2026Belgium
- BioLizardBoard Member2021 — 2026Ghent
- Novalis BiotechFund Manager2019 — 2026
- RheumaFinderBoard Member2023 — 2026
- RheaVita BVBABoard Member2021 — 2026
- Epify BVBoard Member2019 — 2024
- BioLizardInterim Manager2019 — 2020Ghent, Belgium
- Eurofins Amatsigroup (CDMO)Principal Scientist Analytics2016 — 2019Gent Area, Belgium
- AblynxScientist2011 — 2016Zwijnaarde, Belgium
- AnaBioTecProject leader2010 — 2011Zwijnaarde, Belgium
- Baxter BioScienceContinuous Improvement Supervisor QC Lab2009 — 2010Lessines, Belgium
- WatersLC-MS application specialist2006 — 2009Zellik, Belgium
- Ghent University - Faculty of Pharmaceutical Sciences - ToxicologyPhD2000 — 2006
Skills & more
Mass Spectrometry6LC-MS8HPLC2Chromatography7Proteomics2GLP3GMP2ELISA1Chemistry2Bioanalysis5Validation2Pharmacology3
+4 more
Gas ChromatographyFDALife SciencesGood Laboratory Practice (GLP)From Kjell's professional profile.
Colleagues at Novalis Biotech
Bart Rossel
Advisory board member at Novalis Biotech
Cedric Bogaert
Entrepreneur in Residence - managing myNEO at Novalis Biotech
Jan Van den Berghe
Co-Founder / Managing Director at Novalis Biotech
Jaroslav Belotserkovsky
Investment Manager at Novalis Biotech
Kathleen Van den Berghe
Member of the Supervisory Board at Novalis Biotech
Liesbeth Ceelen
Advisory board member at Novalis Biotech
Michael Hengartner
Advisory board member at Novalis Biotech
Wim Van Criekinge
Co-Founder / Managing Director at Novalis Biotech
Frequently asked questions
- Who is Kjell Mortier?
- Kjell Mortier (Pharm., PhD) is a Fund Manager at Novalis. He has around 20 years of experience in the biotech industry across scientific roles in large pharma and CDMO companies, including work on bioanalytical and immunogenicity aspects of (pre-)clinical programs at Ablynx (now part of Sanofi) and CMC-analytical support and technology evaluation at the CRO Eurofins. He also holds a certification in financial analysis from EHSAL Management School.
- Where does Kjell Mortier work?
- Kjell Mortier is Fund Manager at Novalis Biotech.
- What does Kjell Mortier invest in?
- Kjell Mortier invests in Biotech.
- Where did Kjell Mortier go to school?
- Kjell Mortier studied at Guberna - Instituut voor Bestuurders (Board Effectiveness); Guberna - Instituut voor Bestuurders (Director Effectiveness); Vlerick Business School (Venture Capital and Private Equity).
Same school
Also attended Vlerick Business School79
Sabine VermassenExecutive Director at Capricorn Venture PartnersSteven LeveckeExecutive Director at Capricorn Venture PartnersAntoine D'HollanderInvestment Director at Capricorn Venture PartnersFilip PintelonInvestment Partner Health at Capricorn Venture PartnersKobeFinance Director at Hummingbird VenturesLucas De FourLegal Manager at Hummingbird Ventures
+ 73 more
Also attended EHSAL Management School6
Also attended Ghent University87
Sabine VermassenExecutive Director at Capricorn Venture PartnersNoé WachsmuthVisiting Analyst at Capricorn Venture PartnersJeroen Van IseghemInvestment Analyst at Capricorn Venture PartnersLukasPartner at Hummingbird VenturesRoxanneCompliance Officer at Hummingbird VenturesSriram BalusuAssociate at Ysios Capital
+ 81 more
Shared employers
Also worked at BioLizard4
Also worked at RheaVita BVBA1
Also worked at Epify BV1
Also worked at Baxter BioScience39
Brian CheeManaging Partner at Polaris PartnersNick RoelofsVenture Partner at ScietyBengt JulanderSenior Advisor at ScietyRamanathan VStartup Ecosystem Builder at SeafundJulie KimRepresentative Director – President and CEO at Takeda VenturesKavita BjörkdahlInvestor at Almi Invest
+ 33 more


































.avif)








